• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.32% Nasdaq Down 0.01%

    Epizyme, Inc. (EPZM)

    -NasdaqGS
    22.31 Down 0.02(0.09%) Jul 31, 4:00PM EDT
    |After Hours : 21.79 Down 0.52 (2.33%) Jul 31, 7:23PM EDT
    Add to Portfolio
    Prev Close:22.33
    Open:22.42
    Bid:21.75 x 100
    Ask:27.31 x 1000
    1y Target Est:35.57
    Beta:0.74
    Next Earnings Date: 6-Aug-15EPZM Earnings announcement
    Day's Range:22.06 - 23.35
    52wk Range:15.51 - 40.98
    Volume:189,046
    Avg Vol (3m):463,705
    Market Cap:919.28M
    P/E (ttm):N/A
    EPS (ttm):-3.22
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for EPZM

    Comparison

    Symbol% ChgMkt Cap
    EPZMDown 0.09%919.28M
    GSKDown 0.34%104.91B
    NVSUp 0.55%250.57B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):31.80
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-3.85
    Quarterly EPS Est (Jun-15) :-0.70
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Epizyme, Inc., a clinical stage biopharmaceutical company, discovers and develops epigenetic therapies for cancer patients. Its proprietary product platform creates small molecule inhibitors of a 96-member class of enzymes known as histone methylt... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback